🔗 Permalink

Inventor profile of:

William BRADY

City:

Bothell, Washington

Country:

United States

Published Applications:

Last publication date:

2020-11-12

Top Assignees for applications by William BRADY

The entities that hold a legal rights for patent applications filed by inventor BRADY William:

Emergent Product Development Seattle, LLC 10 Seattle, WA United States
TRUBION PHARMACEUTICALS, INC. 9 Seattle, WA United States
BRISTOL-MYERS SQUIBB COMPANY 5 Princeton, NJ United States
APTEVO RESEARCH AND DEVELOPMENT LLC 3 SEATTLE, WA United States
Wyeth 1 Madison, NJ United States

Recent patent applications by BRADY William

William BRADY from Bothell, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-11-12

US20200354447A1

Chemistry; metallurgy

SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION

#2 | 2019-09-26

US20190290755A1

Human necessities

B-CELL REDUCTION USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES

#3 | 2018-05-03

US20180118823A1

Chemistry; metallurgy

SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION

#4 | 2014-06-05

US20140154252A1

Chemistry; metallurgy

SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION

#5 | 2014-06-05

US20140154250A1

Chemistry; metallurgy

SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION

#6 | 2014-05-22

US20140141022A1

Chemistry; metallurgy

SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION

#7 | 2014-05-08

US20140127203A1

Chemistry; metallurgy

SINGLE-CHAIN MULTIVALENT BINDING PROTEINS EFFECTOR FUNCTION

#8 | 2014-03-27

US20140086903A1

Human necessities

CD37 IMMUNOTHERAPEUTIC AND COMBINATION WITH BIFUNCTIONAL CHEMOTHERAPEUTIC THEREOF

#9 | 2014-03-13

US20140072562A1

Human necessities

B-CELL REDUCTION USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES

#10 | 2014-01-09

US20140010813A1

Chemistry; metallurgy

B-CELL REDUCTION USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES

#11 | 2014-01-02

US20140004117A1

Chemistry; metallurgy

B-cell reduction using CD37-specific and CD20-specific binding molecules

#12 | 2013-12-19

US20130336977A1

Chemistry; metallurgy

SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION

#13 | 2013-10-10

US20130266561A1

Chemistry; metallurgy

B-CELL REDUCTION USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES

#14 | 2013-08-01

US20130195850A1

Chemistry; metallurgy

CD3 IMMUNOTHERAPEUTICS AND USES THEREOF

#15 | 2012-02-09

US20120034245A9

Chemistry; metallurgy

Single chain multivalent binding proteins with effector function

#16 | 2011-07-14

US20110171208A1

Human necessities

CD37 immunotherapeutics and uses thereof

#17 | 2011-02-10

US20110033483A1

Chemistry; metallurgy

SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION

#18 | 2010-12-30

US20100330089A1

Chemistry; metallurgy

ANTI-CD20 THERAPEUTIC COMPOSITIONS AND METHODS

#19 | 2009-12-24

US20090317397A1

Chemistry; metallurgy

Soluble CTLA4 mutant molecules and uses thereof

#20 | 2009-11-05

US20090274692A1

Human necessities

CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof

#21 | 2009-08-27

US20090214539A1

Human necessities

B-CELL REDUCTION USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES

#22 | 2009-07-09

US20090175867A1

Chemistry; metallurgy

Single-Chain Multivalent Binding Proteins with Effector Function

#23 | 2009-06-11

US20090148447A1

Chemistry; metallurgy

Binding Peptides Having a C-terminally Disposed Specific Binding Domain

#24 | 2008-11-13

US20080279850A1

Chemistry; metallurgy

B-Cell Reduction Using CD37-Specific and CD20-Specific Binding Molecules

#25 | 2008-02-07

US20080031876A1

Chemistry; metallurgy

Soluble CTLA4 mutant molecules

#26 | 2007-03-15

US20070059306A1

Human necessities

CD37 immunotherapeutics and uses thereof

#27 | 2006-09-12

US9609915

Soluble CTLA4 mutant molecules and uses thereof

#28 | 2006-07-04

US8459766

Methods for blocking binding of CD28 receptor to B7

#29 | 2005-08-04

US20050169919A1

Chemistry; metallurgy

Methods for treating cancer and infectious disease by blocking CTLA4-B7 interactions

#30 | 2005-05-03

US9454651

Method to inhibit T cell interactions with soluble B7

InventorID:

364737 ⎘